Management Change at BayBG: Stefan Koller and Andreas Käufl Appointed Managing Directors
02 April 2026
BayBG announces a management transition: Stefan Koller joins as Managing Director as of April 1, 2026. Together with long-standing CFO Andreas Käufl and CEO Peter Pauli, he will form a three-member leadership team.
Successful Exit: BayBG Venture Capital Sells Its Stake in Specialty Pharma Company AMW
05 March 2026
BayBG Venture Capital successfully exits AMW, a specialty pharma company for biodegradable drug delivery systems. Ren Life Sciences and Juno Capital Partners become new majority shareholders as AMW enters its next growth phase.
Family-owned businesses face complex financing decisions. The event hosted by BayBG and Alphazirkel highlighted which financing models enable growth while preserving entrepreneurial identity.
)
)
)
)
)
)
)
)